Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)

NCT01106833 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

151

Enrollment

OTHER

Sponsor class

Conditions

Chronic GVHD

Interventions

DRUG: Sirolimus + calcineurin inhibitor + prednisone
DRUG: Sirolimus + prednisone

Sponsor

Medical College of Wisconsin

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]